|
US6184024B1
(en)
|
1988-07-14 |
2001-02-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric and/or growth-restricted flaviviruses
|
|
US6190859B1
(en)
|
1995-04-17 |
2001-02-20 |
The United States Of America As Represented By The Secretary Of The Army |
Method and kit for detection of dengue virus
|
|
US6254873B1
(en)
|
1995-04-17 |
2001-07-03 |
The United States Of America As Represented By The Secretary Of The Army |
Inactivated dengue virus vaccine
|
|
WO1996040933A1
(en)
|
1995-06-07 |
1996-12-19 |
The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services |
Infectious dengue 2 virus pdk-53 as quadravalent vaccine
|
|
EP0836090A1
(en)
|
1996-10-12 |
1998-04-15 |
Evotec BioSystems GmbH |
Method of analysis of samples by determination of the distribution of specific brightnesses of particles
|
|
ES2244050T3
(es)
|
1997-02-28 |
2005-12-01 |
Acambis Inc. |
Vacunas quimericas de flavivirus.
|
|
KR20010022452A
(ko)
|
1997-07-31 |
2001-03-15 |
추후제출 |
플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
|
|
WO2000014245A1
(en)
|
1998-09-02 |
2000-03-16 |
The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services |
Dengue viruses that are replication defective in mosquitos for use as vaccines
|
|
US6511667B1
(en)
|
1999-03-26 |
2003-01-28 |
The United States Of America As Represented By The Secretary Of The Army |
Attenuated dengue-2 virus vaccine
|
|
DE60041250D1
(de)
|
1999-03-26 |
2009-02-12 |
Us Army |
Multivalenter dengue-virus impfstoff
|
|
AU4040400A
(en)
|
1999-03-26 |
2000-10-16 |
Walter Reed Army Institute Of Research |
Attenuated dengue-4 virus vaccine
|
|
JP2002540169A
(ja)
|
1999-03-26 |
2002-11-26 |
ウォルター リード アーミー インスティテュート オブ リサーチ |
弱毒化デング熱１型ウイルスワクチン
|
|
US6432411B1
(en)
|
1999-07-13 |
2002-08-13 |
Hawaii Biotechnology Group |
Recombinant envelope vaccine against flavivirus infection
|
|
CA2966716C
(en)
|
2001-05-22 |
2019-11-26 |
The Government Of The United States Of America, As Represented By The Cretary, Department Of Health And Human Services |
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
|
|
EP2295023A1
(en)
|
2002-01-15 |
2011-03-16 |
Sanofi Pasteur Biologics Co. |
Flavivirus vaccines
|
|
PT2338508T
(pt)
|
2002-05-03 |
2018-05-16 |
The Government Of The Us Secretary Department Of Health And Human Services |
Vírus da dengue quimérico recombinante rden3/4delta30(me), rden2/4delta30(me) ou rden1/4delta30(me) contendo uma deleção de 30 nucleótidos (delta30) numa secção da região não traduzida a 3¿ do genoma da dengue de tipo 4, em que a referida deleção de 30 nucleótidos corresponde à estrutura em gancho de cabelo tl2
|
|
AU2003239932A1
(en)
|
2002-05-31 |
2003-12-19 |
Acambis, Inc. |
Tetravalent dengue vaccines
|
|
US7189403B2
(en)
|
2003-06-30 |
2007-03-13 |
Institut Pasteur |
Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
|
|
EP1699814A4
(en)
|
2003-12-08 |
2009-01-14 |
Hybridon Inc |
MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF COMPOUNDS FORMED FROM SMALL OLIGONUCLEOTIDES
|
|
NZ584079A
(en)
|
2004-10-20 |
2011-10-28 |
Acambis Inc |
Vaccines against japanese encephalitis virus and west nile virus
|
|
CA2611934C
(en)
|
2005-06-17 |
2015-11-03 |
Sanofi Pasteur |
Dengue serotype 1 attenuated strain
|
|
MX2007015872A
(es)
|
2005-06-17 |
2008-04-21 |
Sanofi Pasteur |
Cepa atenuada del serotipo 2 del dengue.
|
|
US8048429B2
(en)
|
2005-06-24 |
2011-11-01 |
Intervet International B.V. |
Inactivated chimeric flavivirus
|
|
WO2007015783A2
(en)
|
2005-07-22 |
2007-02-08 |
Research Development Foundation |
Attenuated strains of flaviviruses , and uses thereof
|
|
US7470674B2
(en)
|
2005-11-07 |
2008-12-30 |
Idera Pharmaceuticals, Inc. |
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
|
|
AR061197A1
(es)
|
2006-06-07 |
2008-08-13 |
Sanofi Pasteur |
Cepas del virus 3 del dengue vivas atenuadas
|
|
EP2589602B1
(en)
|
2006-08-15 |
2016-04-06 |
The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health |
Development of dengue virus vaccine components
|
|
FR2906724B1
(fr)
|
2006-10-04 |
2009-03-20 |
Sanofi Pasteur Sa |
Methode d'immunisation contre les 4 serotypes de la dengue.
|
|
US8440202B2
(en)
|
2006-11-09 |
2013-05-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Induction of an immune response against dengue virus using the prime-boost approach
|
|
EP2462930B1
(en)
|
2006-11-09 |
2017-05-31 |
The United States Of America As Represented By The Secretary Of The Navy |
Induction of an immune response against dengue virus using prime-boost approach
|
|
BRPI0904020B8
(pt)
|
2009-10-01 |
2021-05-25 |
Fundacao Oswaldo Cruz |
composição vacinal contra o vírus da dengue, e, kit
|
|
WO2012154202A1
(en)
*
|
2010-10-29 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Recombinant subunit dengue virus vaccine
|
|
US20120294889A1
(en)
*
|
2010-11-12 |
2012-11-22 |
Paxvax, Inc. |
Chimeric Flavivirus Vaccines
|
|
WO2014016362A1
(en)
*
|
2012-07-24 |
2014-01-30 |
Sanofi Pasteur |
Vaccine compositions for prevention against dengue virus infection
|
|
US9861692B2
(en)
|
2013-06-21 |
2018-01-09 |
Merck Sharp & Dohme Corp. |
Dengue virus vaccine compositions and methods of use thereof
|